Literature DB >> 29744346

Beyond the liver in patients with non-alcoholic fatty liver disease (NAFLD)-cause for concern?

Matthew J Armstrong1,2, Geoffrey Haydon1, Wing-Kin Syn3,4.   

Abstract

Entities:  

Year:  2018        PMID： 29744346      PMCID： PMC5934133          DOI： 10.21037/hbsn.2018.01.09

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

1.  Liver fat, statin use, and incident diabetes: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Ravi V Shah; Matthew A Allison; João A C Lima; David A Bluemke; Siddique A Abbasi; Pamela Ouyang; Michael Jerosch-Herold; Jingzhong Ding; Matthew J Budoff; Venkatesh L Murthy
Journal:  Atherosclerosis       Date:  2015-07-15       Impact factor: 5.162

2.  Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study.

Authors:  Sung Keun Park; Mi Hae Seo; Ho Cheol Shin; Jae-Hong Ryoo
Journal:  Hepatology       Date:  2013-04       Impact factor: 17.425

3.  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.

Authors:  Mattias Ekstedt; Hannes Hagström; Patrik Nasr; Mats Fredrikson; Per Stål; Stergios Kechagias; Rolf Hultcrantz
Journal:  Hepatology       Date:  2015-03-23       Impact factor: 17.425

4.  Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study.

Authors:  Xian-Feng Lin; Ke-Qing Shi; Jie You; Wen-Yue Liu; Ying-Wan Luo; Fa-Ling Wu; Yong-Ping Chen; Danny Ka-Ho Wong; Man-Fung Yuen; Ming-Hua Zheng
Journal:  Mol Biol Rep       Date:  2014-01-22       Impact factor: 2.316

Review 5.  Extrahepatic complications of nonalcoholic fatty liver disease.

Authors:  Matthew J Armstrong; Leon A Adams; Ali Canbay; Wing-Kin Syn
Journal:  Hepatology       Date:  2014-01-16       Impact factor: 17.425

Review 6.  A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?

Authors:  Ebenezer T Oni; Arthur S Agatston; Michael J Blaha; Jonathan Fialkow; Ricardo Cury; Andrei Sposito; Raimund Erbel; Ron Blankstein; Ted Feldman; Mouaz H Al-Mallah; Raul D Santos; Matthew J Budoff; Khurram Nasir
Journal:  Atherosclerosis       Date:  2013-08-09       Impact factor: 5.162

7.  Long-term follow-up of patients with NAFLD and elevated liver enzymes.

Authors:  Mattias Ekstedt; Lennart E Franzén; Ulrik L Mathiesen; Lars Thorelius; Marika Holmqvist; Göran Bodemar; Stergios Kechagias
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

8.  Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.

Authors:  Giovanni Targher; Christopher D Byrne; Amedeo Lonardo; Giacomo Zoppini; Corrado Barbui
Journal:  J Hepatol       Date:  2016-05-17       Impact factor: 25.083

Review 9.  Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Giovanni Musso; Roberto Gambino; James H Tabibian; Mattias Ekstedt; Stergios Kechagias; Masahide Hamaguchi; Rolf Hultcrantz; Hannes Hagström; Seung Kew Yoon; Phunchai Charatcharoenwitthaya; Jacob George; Francisco Barrera; Svanhildur Hafliðadóttir; Einar Stefan Björnsson; Matthew J Armstrong; Laurence J Hopkins; Xin Gao; Sven Francque; An Verrijken; Yusuf Yilmaz; Keith D Lindor; Michael Charlton; Robin Haring; Markus M Lerch; Rainer Rettig; Henry Völzke; Seungho Ryu; Guolin Li; Linda L Wong; Mariana Machado; Helena Cortez-Pinto; Kohichiroh Yasui; Maurizio Cassader
Journal:  PLoS Med       Date:  2014-07-22       Impact factor: 11.069

10.  The association of fatty liver and diabetes risk.

Authors:  Masako Okamoto; Yasuhisa Takeda; Yoshioki Yoda; Kazuhisa Kobayashi; Masayuki A Fujino; Zentaro Yamagata
Journal:  J Epidemiol       Date:  2003-01       Impact factor: 3.809
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.